Table 1

Characteristics of the study sample of patients
Characteristic Value
Age (years) 62.5 ± 12.1
Sex (male/female, %) 63.5/36.5
Family history of hypertension (yes/no, %) 56.5/43.5
Family history of stroke (yes/no, %) 19.5/80.5
Smokers (yes/ex/no, %) 17.5/21/61.5
Diabetes (yes/no, %) 10/90
Diastolic BP (mmHg) 75.6 ± 12.0
Systolic BP (mmHg) 133.2 ± 22.6
Pulse pressure (mmHg) 57.6 ± 17.8
Fasting blood glucose (mmHg) 102.7 ± 24.1
Total Cholesterol (mg/dl) 185.8 ± 40.6
BMI (kg/m2) 27.7 ± 4.6
Beta-blockers (yes/no, %) 33.5/66.5
Alphabeta-blockers (yes/no, %) 10.5/89.5
Alpha-blockers (yes/no, %) 8/92
Diuretics (yes/no, %) 43.5/56.5
ACE inhibitor (yes/no, %) 37.5/62.5
Dihydropyridine (yes/no, %) 26/74
eGFR (mL/min/1.73 m2) 77.0 ± 18.9
Kidney Involvement (group 1/ 2 /3 %) 24/59.5/16.5
IMT (mm) 2.24 ± 1.56
Vascular abnormalities (no/ thickening/plaque, %) 13/11/78
LVMi g/m2 130.5 ± 31.0
Left Ventricular hypertrophy (no/yes, %) 40/60

Data are expressed as mean and standard deviation for continuous variables (i.e. age) and as percentage of patients per each group for categorical variables (i.e. gender).

Melillo et al.

Melillo et al. BMC Cardiovascular Disorders 2012 12:105   doi:10.1186/1471-2261-12-105

Open Data